• Main Page • Risk Factors • Symptoms • Diagnosis • Treatment • Screening • Reducing Your Risk • Talking to Your Doctor • Living With Alzheimer's Disease • Resource Guide
Diagnosis of Alzheimer’s Disease
Your doctor will ask about your symptoms and medical history. A physical exam will be done. Your doctor will make a diagnosis of Alzheimer's after a thorough clinical evaluation and a series of tests. Other tests may include those which will increase or decrease the likelihood that you have Alzheimer’s disease. Your doctor will also perform tests to eliminate the possibility of other conditions causing the dementia.
Tests to Assess Dementia
These tests help determine if you have signs of dementia, how severe the dementia is, or to look for other causes of dementia. They may include:
Additionally, electroencephalogram (EEG) is a test that evaluates and follows the electrical activity of the brain. It is not a common test for evaluating most dementias, but it may be done.
Blood and Urine Tests
Blood and urine tests may be ordered to look for other conditions that cause dementia. The tests may include:
Genetic tests can look for markers that increase your risk for early-onset Alzheimer’s. Your doctor may recommend this test if you have family members with this condition.
An Alzheimer’s disease diagnosis usually falls into one of three categories:
Alzheimer's disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed.ebscohost.com/about/about-us . Updated August 19, 2013. Accessed September 5, 2013.
Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at: http://www.nia.nih.gov/Alzheimers/Publications/medicationsfs.htm . Updated July 2010. Accessed September 5, 2013.
Bombois S, Duhamel A, Salleron J, et al. A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer’s diagnosis. Curr Alzheimer Res. 2013;10(4):357-64.
Frisoni GB, Bocchetta M, et al. Imaging markers for Alzheimer disease: Which vs how. Neurology. 2013;81(5):487-500.
Ghidoni R, Benussi L, et al. Cerebrospinal fluid biomarkers in Alzheimer’s disease: the present and the future. Neurodegen Dis. 2011;8:413-420.
Hampel H, Frank R, Broich K, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9(7):560-574.
Riverol M, Lopez OL. Biomarkers in Alzheimer’s disease. Front Neurol. 2011;2:46.
What is Alzheimer's? Alzheimer’s Association website. Available at: http://www.alz.org/alzheimers_disease_what_is_alzheimers.asp . Accessed September 5, 2013.
Last reviewed September 2013 by Rimas Lukas, MD
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org